Paediatric Reference Ranges for Urinary Catecholamines/Metabolites and Their Relevance in Neuroblastoma Diagnosis
- 1 January 1994
- journal article
- review article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 31 (1) , 1-11
- https://doi.org/10.1177/000456329403100101
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Neuroblastoma: A 32‐year population‐based study—implications for screeningMedical and Pediatric Oncology, 1993
- Past and Future of Neuroblastoma Screening in JapanJournal of Pediatric Hematology/Oncology, 1992
- Mass Screening of Neuroblastoma in Sapporo City, JapanJournal of Pediatric Hematology/Oncology, 1992
- NeuroblastomaJournal of Pediatric Hematology/Oncology, 1992
- Long-term Effects of Mass Screening for Neuroblastoma in InfancyJournal of Pediatric Hematology/Oncology, 1991
- Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastomaEuropean Journal of Pediatrics, 1990
- A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVAJournal of Pediatric Surgery, 1989
- Age-related changes in catecholamine metabolites of human urine from birth to adulthoodJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979
- Urinary catecholamines and metabolites in childrenThe Journal of Pediatrics, 1978
- COLORIMETRIC ESTIMATION OF 3-METHOXY-4-HYDROXYMANDELIC ACID IN URINEThe Lancet, 1959